{"id":6170,"date":"2015-07-07T10:13:37","date_gmt":"2015-07-07T10:13:37","guid":{"rendered":"\/?p=6170"},"modified":"2015-07-07T10:39:31","modified_gmt":"2015-07-07T10:39:31","slug":"pharmacyte-biotech-inc-otcmktspmcbs-slide-continues","status":"publish","type":"post","link":"\/articles\/pharmacyte-biotech-inc-otcmktspmcbs-slide-continues\/","title":{"rendered":"Pharmacyte Biotech Inc. (OTCMKTS:PMCB)&#8217;s Slide Continues"},"content":{"rendered":"\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/90\/90639\/fsadfas.png\" border=\"0\" width=\"438\" height=\"195\" \/>Pharmacyte Biotech Inc. (OTCMKTS:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a>) lost another 5.26% of its market cap last Thursday, dropping below the starting point of its latest ascent. <\/p>\n<p>The announcement that <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a> <\/strong>was to be featured in a news magazine on the Discovery Channel&#8217;s &ldquo;NewsWatch&rdquo; certainly attracted the investor&#8217;s attention and aroused some enthusiasm. The hype created this way broke the ticker&#8217;s descent for a session, but it was clear that such a state of developments could not last. Why?<\/p>\n<p>Because <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a> <\/strong>may talk big and take compliments well, but its achievements up to this point are not impressive at all &ndash; and its latest filing can certainly attest to that:<\/p>\n<ul>\n<li>$958 thousand in cash<\/li>\n<li>$378 thousand in total liabilities<\/li>\n<li>ZERO in revenues<\/li>\n<li>$1.45 million in quarterly net loss<\/li>\n<\/ul>\n<p>While this is certainly not the worst 10-Q on the OTC Markets QB section, it does not make <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a> <\/strong>look like it is worth the hype, or the praise. However, that&#8217;s practically a given, seeing as how much of said praise has come from paid promotions by notorious pumper outfits such as OTCJournal and JetLife.<\/p>\n<p>In conclusion &ndash; <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a> <\/strong>managed to spike on hype in spite of its largely unimpressive achievements to date &ndash; which is why its share price is currently going downhill. This turn of events has demonstrated that the ticker hasn&#8217;t completely lost its volatility, in spite of being exposed to a protracted pump campaign &ndash; which proves that there are still some money to be made out of it.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: left;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/90\/90639\/pharmacytebiotech_logo.png\" border=\"0\" width=\"195\" height=\"39\" \/>However, investors should be extra careful when dealing with this company&#8217;s stock, as <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=PMCB\">PMCB<\/a> <\/strong>is nothing like consistent or predictable.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmacyte Biotech Inc. (OTCMKTS:PMCB) lost another 5.26% of its market cap last Thursday, dropping below the starting point of its latest ascent. The announcement that PMCB was to be featured in a news magazine&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1635],"class_list":["post-6170","post","type-post","status-publish","format-standard","hentry","category-news","tag-pmcb"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=6170"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/6170\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=6170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=6170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=6170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}